{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:43:15Z","timestamp":1793245395566,"version":"4.5.0"},"reference-count":30,"publisher":"Society of Nuclear Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.2967\/jnumed.122.264363","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T23:00:18Z","timestamp":1668726018000},"page":"567-573","source":"Crossref","is-referenced-by-count":34,"title":["Interim Analysis of a Prospective Validation of 2 Blood-Based Genomic Assessments (PPQ and NETest) to Determine the Clinical Efficacy of<sup>177<\/sup>Lu-DOTATATE in Neuroendocrine Tumors"],"prefix":"10.2967","volume":"64","author":[{"given":"Lisa","family":"Bodei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitya","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Mauguen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Reidy-Lagunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Sch\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"key":"2023040307200722000_64.4.567.1","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1016\/S1470-2045(20)30323-5","article-title":"Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy","volume":"21","author":"Bodei","year":"2020","journal-title":"Lancet Oncol."},{"key":"2023040307200722000_64.4.567.2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.2553"},{"key":"2023040307200722000_64.4.567.3","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-09-0078"},{"key":"2023040307200722000_64.4.567.4","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3390\/diagnostics10121083","article-title":"The challenge of evaluating response to peptide receptor radionuclide therapy in gastroenteropancreatic neuroendocrine tumors: the present and the future","volume":"10","author":"Liberini","year":"2020","journal-title":"Diagnostics (Basel)."},{"key":"2023040307200722000_64.4.567.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607427"},{"key":"2023040307200722000_64.4.567.6","doi-asserted-by":"crossref","first-page":"16932","DOI":"10.18632\/oncotarget.24524","article-title":"Results and adverse events of personalized peptide receptor radionuclide therapy with 90yttrium and 177lutetium in 1048 patients with neuroendocrine neoplasms","volume":"9","author":"Baum","year":"2018","journal-title":"Oncotarget."},{"key":"2023040307200722000_64.4.567.7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11154-020-09581-6","article-title":"PRRT: identikit of the perfect patient","volume":"22","author":"Albertelli","year":"2021","journal-title":"Rev Endocr Metab Disord."},{"key":"2023040307200722000_64.4.567.8","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0891"},{"key":"2023040307200722000_64.4.567.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.06.014"},{"key":"2023040307200722000_64.4.567.10","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-13-348"},{"key":"2023040307200722000_64.4.567.11","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00259-018-3967-6","article-title":"PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy","volume":"45","author":"Bodei","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023040307200722000_64.4.567.12","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.26"},{"key":"2023040307200722000_64.4.567.13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063364"},{"key":"2023040307200722000_64.4.567.14","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-3378"},{"key":"2023040307200722000_64.4.567.15","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1530\/ERC-21-0216","article-title":"A novel liquid biopsy (NETest) identifies paragangliomas and pheochromocytomas with high accuracy","volume":"28","author":"Pacak","year":"2021","journal-title":"Endocr Relat Cancer."},{"key":"2023040307200722000_64.4.567.16","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0623"},{"key":"2023040307200722000_64.4.567.17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.annonc.2019.11.003","article-title":"A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood","volume":"31","author":"\u00d6berg","year":"2020","journal-title":"Ann Oncol."},{"key":"2023040307200722000_64.4.567.18","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-15-0092"},{"key":"2023040307200722000_64.4.567.19","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00259-019-04601-3","article-title":"PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest","volume":"47","author":"Bodei","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023040307200722000_64.4.567.20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000367850","article-title":"The status of neuroendocrine tumor imaging: from darkness to light?","volume":"101","author":"Bodei","year":"2015","journal-title":"Neuroendocrinology."},{"key":"2023040307200722000_64.4.567.21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.3049"},{"key":"2023040307200722000_64.4.567.22","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-16-0524"},{"key":"2023040307200722000_64.4.567.23","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-017-0271-4"},{"key":"2023040307200722000_64.4.567.24","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00259-015-3250-z","article-title":"Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors","volume":"43","author":"Bodei","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023040307200722000_64.4.567.25","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-1026"},{"key":"2023040307200722000_64.4.567.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2014.12.006"},{"key":"2023040307200722000_64.4.567.27","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.256727"},{"key":"2023040307200722000_64.4.567.28","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-018-2450-x"},{"key":"2023040307200722000_64.4.567.29","doi-asserted-by":"publisher","DOI":"10.1038\/nature21063"},{"key":"2023040307200722000_64.4.567.30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12885-021-07786-9","article-title":"SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors","volume":"21","author":"Hofving","year":"2021","journal-title":"BMC Cancer."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.122.264363","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T14:26:18Z","timestamp":1680531978000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.122.264363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,3]]},"published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.2967\/jnumed.122.264363"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.122.264363","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,17]]}}}